Last reviewed · How we verify

NCT00060736

The Effects of Estrogen Withdrawal on Mood Symptoms in Women

Completed Last updated 16 December 2019
What this trial tests

trial in Perimenopausal Depression in 60 participants. Completed in 27 April 2016.

Timeline
5 May 2003
27 April 2016

Quick facts

Lead sponsorNational Institute of Mental Health (NIMH)
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date5 May 2003
Estimated completion27 April 2016
Sites1 location across United States

Conditions studied

Sponsor

National Institute of Mental Health (NIMH)

Who can join

Adults 45 to 65, female only, with Perimenopausal Depression or Post Menopausal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effects on mood when stopping estrogen replacement therapy. The purpose of this study is to investigate the effects of estrogen levels on perimenopausal depression. This study will examine short-term withdrawal of estrogen in women whose mood had improved with estrogen therapy. Perimenopause-related mood disorders cause significant distress in a large number of women. Evidence suggests that estradiol may have beneficial effects in women with perimenopausal depression. However, the effect of declining estradiol secretion during perimenopause has not been fully examined. Peri- and post-menopausal women who experience a remission of perimenopause-related depression symptoms while on estrogen therapy and a control group of healthy volunteers on hormone replacement therapy (HRT) will be switched from their current form of HRT to estradiol for a 3-week period; volunteers will also complete symptom ratings to confirm the absence of mood symptoms. Participants will then be randomly assigned to either continue estradiol or take a placebo (an inactive pill) for an additional 3 weeks. Mood ratings will be used to determine response to estradiol withdrawal. ...

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
    Schmidt PJ, Ben Dor R, Martinez PE, Guerrieri GM, et al · · 2015 · cited 161× · PMID 26018333 · DOI 10.1001/jamapsychiatry.2015.0111
  2. In vitro model of perimenopausal depression implicates steroid metabolic and proinflammatory genes.
    Rudzinskas S, Hoffman JF, Martinez P, Rubinow DR, et al · · 2021 · cited 11× · PMID 32788687 · DOI 10.1038/s41380-020-00860-x

Verify or expand the search:

Other National Institute of Mental Health (NIMH) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00060736.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing